NEOTROFIN
USPTO Trademark Record · Serial No. 75215282
Trademark details
It was initially claimed by SPECTRUM PHARMACEUTIALS, INC. on 19961218.
That brand applies to the following goods and services:pharmaceutical compounds that act on the central nervous system to treat neurodegenerative diseases and conditions such as memory deficits associated with Alzheimer's disease, impairment associated with the dementia of aging, stroke, and the neurological aspects of AIDS, as well as spinal cord injuries, expressly excluding pharmaceuticals for the treatment of amyotrophic lateral sclerosis, multiple sclerois and/or peripheral neuropathy.
Currently that trademark is represented by trademark attorney(s): Louis C. Cullman.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the NEOTROFIN trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
